![]() |
|
Hosted on behalf of the European Commission![]() |
EudraCT step-by-step guide |
||
For a trial conducted in the European Economic Area:All clinical trials in the European Union (EU)/European Economic Area (EEA) that are ongoing after 30 January 2025 must comply with the Clinical Trial Regulation (EU) 536/2014 and, therefore, should have been submitted to the Clinical Trials Information System (CTIS). More information here.The procedure below is applicable to all EudraCT Clinical Trial Applications of trials that were ended in the EU/EEA before January 31st, 2025. Sponsor, once the trial has ended:
For a trial to be conducted exclusively outside of the EEA, but part of a PIP/Art 46 of the paediatric regulation:The below is applicable to trials that are conducted exclusively outside of the EU/EEA but, that are part of a Paediatric Investigation Plan and/or in scope of Art 46 of the paediatric regulation (EC) No 1901/2006 (“third country files”). For PIP/Art 46 trials that will be conducted in the EU/EEA as well as outside of the EU/EEA, the initial submission must be performed solely through CTIS.Sponsor (third country data provider):
|
||
|